Table 3.
Syndrome/medical disorder | Responsible gene | Author (year) |
---|---|---|
Anhidrotic ectodermal dysplasia | EDA | Anbouba et al. (2020) [58] |
Cleft lip and palate | TGFB3, MSX 1 | Tannure et al. (2012) [59] |
Down syndrome | Trisomy 21 | Cobourne (2007) [2] |
Ehlers Danlos syndrome | ADAMTS2 | Colige et al. (1999) [61] |
Fraser Syndrome | FRAS1, FREM2, and GRIP1 | Kunz et al. (2020) [65] |
Hemifacial Microsomia | OTX2, PLCD3, and MYT1 | Chen et al. (2018) [64] |
Incontentia pigmenti | NEMO | Smahi et al. (2000) [62] |
Limb mammary syndrome | TP63 | Van Bokhoven et al. (2001) [63] |
Popliteal Petrygium Syndrome | Irf6 | Wu Chou et al. (2013) [67] |
Rieger syndrome (Type 1) | Pitx2 | Semina et al. (1996) [60] |
Van der Woude syndrome | Irf6 | Wang et al. (2003) [68] |
Wiktop syndrome | Msx 1 | Jumlongras et al. (2001) [66] |
KEY: EDA: ectodysplasin A. TGFB3: Transforming growth factor beta 3. MSX1: Msh homeobox 1. ADAM; A disintegrin and metalloproteinase with thrombospondin motifs 2. FRAS 1: Fraser extracellular matrix complex subunit 1. FREM 2: FRAS1 related extracellular matrix 2. GRIP 1: Glutamate receptor interacting protein OTX 2: Orthodenticle homeobox 2. PLCD3; phospholipase C delta 3. MYT1: Myelin transcription factor 1. Nemo: NF-kappa-B essential modulator. TP63: Tumour protein 63. IRF6: Interferon regulatory factor 6. PITX2: Paired like homeodomain 2.